NSC-Reconstruct participates in EuroGCT: the European Consortium for Communicating Gene and Cell Therapy Information

NSC-Reconstruct participates in EuroGCT, the European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) which brings together 47 partner organisations and institutions across Europe with a goal of providing reliable and accessible information about the use of cells and genetic material to treat disease.

EuroGCT’s two major objectives are:

• To provide patients, people affected by conditions, healthcare professionals, and citizens with accurate scientific, legal, ethical, and societal information related to cell and gene-based therapies.
• To provide the research community and regulatory and healthcare authorities with an information source on the practical steps needed for cell and gene therapy development.

The consortium comprises leading cell and gene therapy-related organisations and research labs across Europe; together with experts in product development, ethical, legal, and societal issues, and in evaluating clinical outcomes; patient representatives; and science communicators.

You can also find more information and resources on stem cells at our sister project, www.eurostemcell.org.